Cathay Biotech Inc (688065.SS) stock: key figures, P/E, revenue and dividend
Materials · Commodity Chemicals · China · ISIN CNE100004447
Cathay Biotech Inc financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.96 bn CNY | 3.30 bn CNY |
| Gross profit | 836.44 m CNY | 635.09 m CNY |
| Operating income | 551.56 m CNY | 635.09 m CNY |
| EBIT | 581.49 m CNY | 631.50 m CNY |
| Net income | 488.96 m CNY | 565.72 m CNY |
| Diluted EPS – continuing operations | 0.84 CNY | 0.83 CNY |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Cathay Biotech Inc
Cathay Biotech Inc., together with its subsidiaries, engages in the research, development, production, and sale of bio-based materials in China and internationally. The company offers biological long-chain diacids, including sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine under the TERRYL and ECOPENT brands. It also provides digital solutions for electrification, automation, and digitization for biological manufacturing. The company's products are used in textiles, pharmaceuticals, automobiles, electronic appliances, consumer goods, engineering materials, and other industries. It exports its products. The company was incorporated in 2000 and is headquartered in Shanghai, China.
More stocks
- Sinomach Precision Industry Co Ltd (002046.SZ)
- WSFS FINANCIAL CORP (WSFS)
- Krones (KRN.DE)
- Capricorn Metals Ltd (CMM.AX)
- Bucher Industries AG (BUCN.SW)
- INDEPENDENT BANK CORP (INDB)
- Leo Group Co Ltd (002131.SZ)
- Zuger Kantonalbank (ZUGER.SW)
- ALASKA AIR GROUP, INC. (ALK)
- Tokyo Seimitsu Co Ltd (7729.T)
- BRADY CORP (BRC)
- iRhythm Holdings, Inc. (IRTC)
Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.